ADME and Predictive Toxicology

Check out our 2for1 offer!

Our 2013 ADME & Predictive Toxicology Congress will report on the vital role ADME and Predictive Toxicology play in aiding successful drug candidate identification and design. Ensuring drugs make it to the market quicker with higher hit rates and earlier indications of human toxicity issues is of the utmost importance and will be discussed at length here.

Our array of Keynote Speakers will give presentations on all areas of ADME/Tox backed up by a panel of experts  speaking on highly relevant and “hot” topics such as Pharmacogenomics and Drug Safety, Genotoxicity and Toxicokinetic Modeling and ADME Optimisation for Drug Design/Discovery.

Running alongside the conference will be an exhibition covering the latest technological advances and associated services within these fields.

Also, co-located with our ADME+Predictive Toxicology conference will be our Nanomedicine meeting.

Session Sponsors

Keynote Speakers

Franck Atienzar Head, UCB Pharma SA

Robert Guttendorf Senior Consultant, DMPK, Aclairo Pharmaceutical Development Group

Magnus Ingelman-Sundberg Professor/Head, Karolinska Institutet